Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
She thought she was having indigestion. Doctors found a near-fatal artery blockage.
For days, she dealt with the nagging pain. One day, she and her daughter went to the mall, and Caprario decided to run up and down the stairs to try and relieve the discomfort. On other days, she ...
MedPage Today on MSN16h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...